Related Experiment Video
Updated: Feb 22, 2026

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
Published on: February 19, 2019
Can we go for a shorter treatment course in chronic hepatitis C? More inspiring cases
Rosa Zampino1, Martina Vitrone1, Antonio Parrella1
1a Internal Medicine, Unit of Infectious & Transplant Medicine A.O.R.N. dei Colli - Ospedale Monaldi , University of Campania, "Luigi Vanvitelli" , Napoli , Italy.
Abstract:
Current interest in HCV therapy with direct acting antivirals is focused on shortening treatment length. We managed two cirrhotics who achieved virological cure after 4 weeks of ombitasvir/paritaprevir/ritonavir, dasabuvir, ribavirin treatment. Analysis to identify potential predictive factors for a successful outcome with a shorter treatment course was conducted.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Retrovirus Life Cycles
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

